Highlights the risk of influenza A myocarditis in vaccinated solid organ transplant recipients due to reduced vaccine response.
Answers are grounded in this paper and cite their sources.
May signal breakthrough myocarditis risk despite vaccination in transplant recipients; hypothesis-generating for enhanced prevention in immunocompromised patients.
Solid organ transplant recipients receiving chronic immunosuppressive agents are at increased risk to acquire influenza virus despite vaccination. Myocarditis is a known but rare complication of influenza infection. We present the first adult liver transplant recipient who received prophylactic vaccination but developed influenza A myocarditis. This may occur in solid organ transplant recipients, because they have reduced response to protein vaccines, which may leave them vulnerable to infections. Studies are needed to evaluate if antiviral chemoprophylaxis in solid organ transplant recipients during influenza season would be an effective preventive therapy against influenza in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Vilchez et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: